Glucose augments killing efficiency of daptomycin challenged Staphylococcus aureus persisters

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Prax, Marcel ^a,b   Mechler, Lukas ^a   Weidenmaier, Christopher ^a   Bertram, Ralph ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b PAUL EHRLICH INSTITUT   (Germany)

^c KLINIKUM NÜRNBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; CARBOHYDRATE TRANSPORT PROTEIN; CARRIER PROTEIN; DAPTOMYCIN; DEOXYGLUCOSE; GLUCOSE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CATABOLISM; CELL DIVISION; COLONY FORMING UNIT; CONTROLLED STUDY; GLUCOSE TRANSPORT; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PH; STAPHYLOCOCCUS AUREUS; DRUG EFFECTS; DRUG POTENTIATION; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG SYNERGISM; GLUCOSE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 84962535109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150907     Document Type: Article

References (78)

1. Moy JA, Caldwell-Brown D, Lin AN, Pappa KA, Carter DM (1990) Mupirocin-resistant Staphylococcus aureus after long-term treatment of patients with epidermolysis bullosa. J Am Acad Dermatol 22: 893-895. PMID: 2112168
2. Endimiani A, Blackford M, Dasenbrook EC, Reed MD, Bajaksouszian S, Hujer AM, et al. (2011) Emergence of linezolid-resistant Staphylococcus aureus after prolonged treatment of cystic fibrosis patients in Cleveland, Ohio. Antimicrob Agents Chemother 55: 1684-1692. doi: 10.1128/AAC.01308-10 PMID: 21263048
3. Mariani PG, Sader HS, Jones RN (2006) Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy. J Antimicrob Chemother 58: 481-483. PMID: 16847029
4. Skiest DJ (2006) Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol 44: 655-656. PMID: 16455939
5. Babra C, Tiwari J, Costantino P, Sunagar R, Isloor S, Hedge N, et al. (2013) Human methicillin-sensitive Staphylococcus aureus biofilms: potential associations with antibiotic resistance persistence and surface polysaccharide antigens. J Basic Microbiol.
6. Donlan RM, Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193. PMID: 11932229
7. Dortet L, Anguel N, Fortineau N, Richard C, Nordmann P (2013) In vivo acquired daptomycin resistance during treatment of methicillin-resistant Staphylococcus aureus endocarditis. Int J Infect Dis 17: e1076-1077. doi: 10.1016/j.ijid.2013.02.019 PMID: 23578850
8. Wood TK, Knabel SJ, Kwan BW (2013) Bacterial persister cell formation and dormancy. Appl Environ Microbiol 79: 7116-7121. doi: 10.1128/AEM.02636-13 PMID: 24038684
9. Lewis K (2010) Persister cells. Annu Rev Microbiol 64: 357-372. doi: 10.1146/annurev.micro.112408. 134306 PMID: 20528688
10. Balaban NQ, Gerdes K, Lewis K, McKinney JD (2013) A problem of persistence: still more questions than answers? Nat Rev Microbiol 11: 587-591. PMID: 24020075
11. Casadesús J, Low DA (2013) Programmed heterogeneity: epigenetic mechanisms in bacteria. J Biol Chem 288: 13929-13935. doi: 10.1074/jbc.R113.472274 PMID: 23592777
12. Helaine S, Kugelberg E (2014) Bacterial persisters: formation, eradication, and experimental systems. Trends Microbiol 22: 417-424. doi: 10.1016/j.tim.2014.03.008 PMID: 24768561
13. Fauvart M, De Groote VN, Michiels J (2011) Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J Med Microbiol 60: 699-709. doi: 10.1099/jmm.0. 030932-0 PMID: 21459912
14. Tuchscherr L, Medina E, Hussain M, Völker W, Heitmann V, Niemann S, et al. (2011) Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med 3: 129-141. doi: 10.1002/emmm.201000115 PMID: 21268281
15. Que YA, Hazan R, Strobel B, Maura D, He J, Kesarwani M, et al. (2013) A quorum sensing small volatile molecule promotes antibiotic tolerance in bacteria. PLoS One 8: e80140. doi: 10.1371/journal. pone.0080140 PMID: 24367477
16. Leung V, Levesque CM (2012) A stress-inducible quorum-sensing peptide mediates the formation of persister cells with noninherited multidrug tolerance. J Bacteriol 194: 2265-2274. doi: 10.1128/JB. 06707-11 PMID: 22366415
17. Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K (2004) Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett 230: 13-18. PMID: 14734160
18. Amato SM, Fazen CH, Henry TC, Mok WW, Orman MA, Sandvik EL, et al. (2014) The role of metabolism in bacterial persistence. Front Microbiol 5: 70. doi: 10.3389/fmicb.2014.00070 PMID: 24624123
19. Amato SM, Orman MA, Brynildsen MP (2013) Metabolic control of persister formation in Escherichia coli. Mol Cell 50: 475-487. doi: 10.1016/j.molcel.2013.04.002 PMID: 23665232
20. Orman MA, Brynildsen MP (2013) Establishment of a Method To Rapidly Assay Bacterial Persister Metabolism. Antimicrobial Agents and Chemotherapy 57: 4398-4409. doi: 10.1128/AAC.00372-13 PMID: 23817376
21. Orman MA, Brynildsen MP (2013) Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob Agents Chemother 57: 3230-3239. doi: 10.1128/AAC.00243-13 PMID: 23629720
22. Bokinsky G, Baidoo EE, Akella S, Burd H, Weaver D, Alonso-Gutierrez J, et al. (2013) HipA-Triggered Growth Arrest and beta-Lactam Tolerance in Escherichia coli Are Mediated by RelA-Dependent ppGpp Synthesis. J Bacteriol 195: 3173-3182. doi: 10.1128/JB.02210-12 PMID: 23667235
23. Lechner S, Prax M, Lange B, Huber C, Eisenreich W, Herbig A, et al. (2014) Metabolic and transcriptional activities of Staphylococcus aureus challenged with high-doses of daptomycin. Int J Med Microbiol 304: 931-940. doi: 10.1016/j.ijmm.2014.05.008 PMID: 24980509
24. Gould IM (2009) Antibiotics, skin and soft tissue infection and meticillin-resistant Staphylococcus aureus: cause and effect. Int J Antimicrob Agents 34 Suppl 1: S8-11. doi: 10.1016/S0924-8579(09) 70542-4 PMID: 19560675
25. Brady RA, Leid JG, Calhoun JH, Costerton JW, Shirtliff ME (2008) Osteomyelitis and the role of biofilms in chronic infection. FEMS Immunol Med Microbiol 52: 13-22. PMID: 18081847
26. Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ (2012) Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis 54: 51-58. doi: 10.1093/cid/cir764 PMID: 22109947
27. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339: 520-532. PMID: 9709046
28. DeLeo FR, Otto M, Kreiswirth BN, Chambers HF (2010) Community-associated meticillin-resistant Staphylococcus aureus. Lancet 375: 1557-1568. doi: 10.1016/S0140-6736(09)61999-1 PMID: 20206987
29. French GL (2006) Bactericidal agents in the treatment of MRSA infections - the potential role of daptomycin. J Antimicrob Chemother 58: 1107-1117. PMID: 17040922
30. Fuchs PC, Barry AL, Brown SD (2002) In vitro bactericidal activity of daptomycin against staphylococci. J Antimicrob Chemother 49: 467-470. PMID: 11864946
31. Steenbergen JN, Alder J, Thorne GM, Tally FP (2005) Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. J Antimicrob Chemother 55: 283-288. PMID: 15705644
32. Mascio CT, Alder JD, Silverman JA (2007) Bactericidal action of daptomycin against stationary-phase and nondividing Staphylococcus aureus cells. Antimicrob Agents Chemother 51: 4255-4260. PMID: 17923487
33. Humphries RM, Pollett S, Sakoulas G (2013) A Current Perspective on Daptomycin for the Clinical Microbiologist. Clin Microbiol Rev 26: 759-780. doi: 10.1128/CMR.00030-13 PMID: 24092854
34. Muraih JK, Pearson A, Silverman J, Palmer M (2011) Oligomerization of daptomycin on membranes. Biochim Biophys Acta 1808: 1154-1160. doi: 10.1016/j.bbamem.2011.01.001 PMID: 21223947
35. Lechner S, Lewis K, Bertram R (2012) Staphylococcus aureus Persisters Tolerant to Bactericidal Antibiotics. J Mol Microbiol Biotechnol 22: 235-244. doi: 10.1159/000342449 PMID: 22986269
36. Berti AD, Wergin JE, Girdaukas GG, Hetzel SJ, Sakoulas G, Rose WE (2012) Altering the proclivity towards daptomycin resistance in methicillin-resistant Staphylococcus aureus using combinations with other antibiotics. Antimicrob Agents Chemother 56: 5046-5053. doi: 10.1128/AAC.00502-12 PMID: 22802248
37. Werth BJ, Sakoulas G, Rose WE, Pogliano J, Tewhey R, Rybak MJ (2013) Ceftaroline increases membrane binding and enhances the activity of daptomycin against daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus in a pharmacokinetic/pharmacodynamic model. Antimicrob Agents Chemother 57: 66-73. doi: 10.1128/AAC.01586-12 PMID: 23070161
38. Gasch O, Pillai S, Dakos J, Miyakis S, Moellering R Jr., Eliopoulos G (2013) Daptomycin in vitro activity against methicillin-resistant Staphylococcus aureus is enhanced by D-cycloserine in a mechanism associated with a decrease in cell surface charge. Antimicrob Agents Chemother.
39. Hayden MK, Rezai K, Hayes RA, Lolans K, Quinn JP, Weinstein RA (2005) Development of Daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 43: 5285-5287. PMID: 16207998
40. Bayer AS, Schneider T, Sahl HG (2013) Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall. Ann N Y Acad Sci 1277: 139-158. doi: 10.1111/j.1749-6632.2012.06819.x PMID: 23215859
41. Song Y, Rubio A, Jayaswal RK, Silverman JA, Wilkinson BJ (2013) Additional routes to Staphylococcus aureus daptomycin resistance as revealed by comparative genome sequencing, transcriptional profiling, and phenotypic studies. PLoS One 8: e58469. doi: 10.1371/journal.pone.0058469 PMID: 23554895
42. Bertsche U, Weidenmaier C, Kuehner D, Yang SJ, Baur S, Wanner S, et al. (2011) Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation. Antimicrob Agents Chemother 55: 3922-3928. doi: 10.1128/AAC.01226-10 PMID: 21606222
43. Cohen NR, Lobritz MA, Collins JJ (2013) Microbial persistence and the road to drug resistance. Cell Host Microbe 13: 632-642. doi: 10.1016/j.chom.2013.05.009 PMID: 23768488
44. Conlon BP, Nakayasu ES, Fleck LE, LaFleur MD, Isabella VM, Coleman K, et al. (2013) Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature 503: 365-370. doi: 10.1038/ nature12790 PMID: 24226776
45. Allison KR, Brynildsen MP, Collins JJ (2011) Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature 473: 216-220. doi: 10.1038/nature10069 PMID: 21562562
46. Barraud N, Buson A, Jarolimek W, Rice SA (2013) Mannitol Enhances Antibiotic Sensitivity of Persister Bacteria in Pseudomonas aeruginosa Biofilms. PLoS One 8: e84220. doi: 10.1371/journal.pone. 0084220 PMID: 24349568
47. Fey PD, Endres JL, Yajjala VK, Widhelm TJ, Boissy RJ, Bose JL, et al. (2013) A genetic resource for rapid and comprehensive phenotype screening of nonessential Staphylococcus aureus genes. MBio 4: e00537-00512. doi: 10.1128/mBio.00537-12 PMID: 23404398
48. Mechler L, Herbig A, Paprotka K, Fraunholz M, Nieselt K, Bertram R (2015) A novel point mutation promotes growth phase-dependent daptomycin tolerance in Staphylococcus aureus. Antimicrob Agents Chemother 59: 5366-5376. doi: 10.1128/AAC.00643-15 PMID: 26100694
49. Hanberger H, Nilsson LE, Maller R, Isaksson B (1991) Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs. Antimicrob Agents Chemother 35: 1710-1716. PMID: 1659305
50. Iordanescu S, Surdeanu M (1976) Two restriction and modification systems in Staphylococcus aureus NCTC8325. J Gen Microbiol 96: 277-281.
51. Herbert S, Ziebandt AK, Ohlsen K, Schäfer T, Hecker M, Albrecht D, et al. (2010) Repair of global regulators in Staphylococcus aureus 8325 and comparative analysis with other clinical isolates. Infect Immun 78: 2877-2889. doi: 10.1128/IAI.00088-10 PMID: 20212089
52. Götz F, Bannerman T., Schleifer KH. (2006) The Genera Staphylococcus and Macrococcus. The Prokaryotes 4: 5-75.
53. Wick AN, Drury DR, Nakada HI, Wolfe JB (1957) Localization of the primary metabolic block produced by 2-deoxyglucose. J Biol Chem 224: 963-969. PMID: 13405925
54. Cavari BZ, Avi-Dor Y (1967) Effect of carbonyl cyanide m-chlorophenylhydrazone on respiration and respiration-dependent phosphorylation in Escherichia coli. Biochem J 103: 601-608. PMID: 4962086
55. Kwan BW, Valenta JA, Benedik MJ, Wood TK (2013) Arrested protein synthesis increases persisterlike cell formation. Antimicrob Agents Chemother 57: 1468-1473. doi: 10.1128/AAC.02135-12 PMID: 23295927
56. Paczia N, Nilgen A, Lehmann T, Gatgens J, Wiechert W, Noack S (2012) Extensive exometabolome analysis reveals extended overflow metabolism in various microorganisms. Microb Cell Fact 11: 122. doi: 10.1186/1475-2859-11-122 PMID: 22963408
57. Somerville GA, Said-Salim B, Wickman JM, Raffel SJ, Kreiswirth BN, Musser JM (2003) Correlation of acetate catabolism and growth yield in Staphylococcus aureus: implications for host-pathogen interactions. Infect Immun 71: 4724-4732. PMID: 12874354
58. Fischer A, Yang SJ, Bayer AS, Vaezzadeh AR, Herzig S, Stenz L, et al. (2011) Daptomycin resistance mechanisms in clinically derived Staphylococcus aureus strains assessed by a combined transcriptomics and proteomics approach. J Antimicrob Chemother 66: 1696-1711. doi: 10.1093/jac/dkr195 PMID: 21622973
59. Cotroneo N, Harris R, Perlmutter N, Beveridge T, Silverman JA (2008) Daptomycin exerts bactericidal activity without lysis of Staphylococcus aureus. Antimicrob Agents Chemother 52: 2223-2225. doi: 10.1128/AAC.01410-07 PMID: 18378708
60. Jahreis K, Pimentel-Schmitt EF, Bruckner R, Titgemeyer F (2008) Ins and outs of glucose transport systems in eubacteria. FEMS Microbiol Rev 32: 891-907. doi: 10.1111/j.1574-6976.2008.00125.x PMID: 18647176
61. Stülke J, Martin-Verstraete I, Zagorec M, Rose M, Klier A, Rapoport G (1997) Induction of the Bacillus subtilis ptsGHI operon by glucose is controlled by a novel antiterminator, GlcT. Mol Microbiol 25: 65-78. PMID: 11902727
62. Diep DB, Skaugen M, Salehian Z, Holo H, Nes IF (2007) Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc Natl Acad Sci U S A 104: 2384-2389. PMID: 17284603
63. Humphries RM, Kelesidis T, Tewhey R, Rose WE, Schork N, Nizet V, et al. (2012) Genotypic and phenotypic evaluation of the evolution of high-level daptomycin nonsusceptibility in vancomycin-resistant Enterococcus faecium. Antimicrob Agents Chemother 56: 6051-6053. doi: 10.1128/AAC.01318-12 PMID: 22948885
64. Wale LJ, Shelton AP, Greenwood D (1989) Scanning electronmicroscopy of Staphylococcus aureus and Enterococcus faecalis exposed to daptomycin. J Med Microbiol 30: 45-49. PMID: 2550648
65. Gustafson JE, Berger-Bachi B, Strassle A, Wilkinson BJ (1992) Autolysis of methicillin-resistant and-susceptible Staphylococcus aureus. Antimicrob Agents Chemother 36: 566-572. PMID: 1320363
66. Bierbaum G, Sahl HG (1985) Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes. Arch Microbiol 141: 249-254. PMID: 4004448
67. Bayles KW (2014) Bacterial programmed cell death: making sense of a paradox. Nat Rev Microbiol 12: 63-69. doi: 10.1038/nrmicro3136 PMID: 24336185
68. Rice KC, Nelson JB, Patton TG, Yang SJ, Bayles KW (2005) Acetic acid induces expression of the Staphylococcus aureus cidABC and lrgAB murein hydrolase regulator operons. Journal of Bacteriology 187: 813-821. PMID: 15659658
69. Yang SJ, Rice KC, Brown RJ, Patton TG, Liou LE, Park YH, et al. (2005) A LysR-type regulator, CidR, is required for induction of the Staphylococcus aureus cidABC operon. Journal of Bacteriology 187: 5893-5900. PMID: 16109930
70. Seidl K, Muller S, Francois P, Kriebitzsch C, Schrenzel J, Engelmann S, et al. (2009) Effect of a glucose impulse on the CcpA regulon in Staphylococcus aureus. BMC Microbiol 9: 95. doi: 10.1186/1471-2180-9-95 PMID: 19450265
71. Rice KC, Bayles KW (2003) Death's toolbox: examining the molecular components of bacterial programmed cell death. Molecular Microbiology 50: 729-738. PMID: 14617136
72. Groicher KH, Firek BA, Fujimoto DF, Bayles KW (2000) The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance. Journal of Bacteriology 182: 1794-1801. PMID: 10714982
73. Pascoe B, Dams L, Wilkinson TS, Harris LG, Bodger O, Mack D, et al. (2014) Dormant Cells of Staphylococcus aureus Are Resuscitated by Spent Culture Supernatant. PLoS One 9: e85998. doi: 10.1371/ journal.pone.0085998 PMID: 24523858
74. Van der Auwera P (1989) Ex vivo study of serum bactericidal titers and killing rates of daptomycin (LY146032) combined or not combined with amikacin compared with those of vancomycin. Antimicrob Agents Chemother 33: 1783-1790. PMID: 2556079
75. Kullar R, Chin JN, Edwards DJ, Parker D, Coplin WM, Rybak MJ (2011) Pharmacokinetics of singledose daptomycin in patients with suspected or confirmed neurological infections. Antimicrob Agents Chemother 55: 3505-3509. doi: 10.1128/AAC.01741-10 PMID: 21502620
76. Friedman L, Alder JD, Silverman JA (2006) Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother 50: 2137-2145. PMID: 16723576
77. Peleg AY, Miyakis S, Ward DV, Earl AM, Rubio A, Cameron DR, et al. (2012) Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus. PLoS One 7: e28316. doi: 10.1371/journal.pone.0028316 PMID: 22238576
78. Gasch O, Camoez M, Dominguez MA, Padilla B, Pintado V, Almirante B, et al. (2013) Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin. J Antimicrob Chemother.